Quinapril treatment curtails decline of global longitudinal strain and mechanical function in hypertensive rats.

Left ventricular (LV) global longitudinal strain (GLS) has been proposed as an early imaging biomarker of cardiac mechanical dysfunction. To assess the impact of angiotensin-converting enzyme (ACE) inhibitor treatment of hypertensive heart disease on LV GLS and mechanical function. The spontaneously hypertensive rat (SHR) model of hypertensive heart disease ( n  = 38) was studied. A subset of SHRs received quinapril (TSHR, n  = 16) from 3 months (mo). Wistar Kyoto rats (WKY, n  = 13) were used as controls. Tagged cardiac MRI was performed using a 4.7 T Varian preclinical scanner. The SHRs had significantly lower LV ejection fraction (EF) than the WKYs at 3 mo (53.0 ± 1.7% vs. 69.6 ± 2.1%, P  < 0.05), 14 mo (57.0 ± 2.5% vs. 74.4 ± 2.9%, P  < 0.05) and 24 mo (50.1 ± 2.4% vs. 67.0 ± 2.0%, P  < 0.01). At 24 mo, ACE inhibitor treatment was associated with significantly greater LV EF in TSHRs compared to untreated SHRs (64.2 ± 3.4% vs. 50.1 ± 2.4%, P  < 0.01). Peak GLS magnitude was significantly lower in SHRs compared with WKYs at 14 months (7.5% ± 0.4% vs. 9.9 ± 0.8%, P  < 0.05). At 24 months, Peak GLS magnitude was significantly lower in SHRs compared with both WKYs (6.5 ± 0.4% vs. 9.7 ± 1.0%, P  < 0.01) and TSHRs (6.5 ± 0.4% vs. 9.6 ± 0.6%, P  < 0.05). ACE inhibitor treatment curtails the decline in global longitudinal strain in hypertensive rats, with the treatment group exhibiting significantly greater LV EF and GLS magnitude at 24 mo compared with untreated SHRs. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Citation

Alexander J Wilson, Gregory B Sands, Vicky Y Wang, Beau Pontre, Daniel B Ennis, Alistair A Young, Ian J LeGrice, Martyn P Nash. Quinapril treatment curtails decline of global longitudinal strain and mechanical function in hypertensive rats. Journal of hypertension. 2023 Oct 01;41(10):1606-1614

Mesh Tags

Substances

PMID: 37466436

search → result